The rise of GLP-1 drugs like Ozempic are changing consumer food waste patterns both at home and in restaurant settings.

Wockhardt will deepen its novel antibiotics pipeline over the next five years and focus on building a biosimilar business for ...

New York’s reputation as a trailblazer for health equity is in danger. We must ensure equity in obesity treatment.

Linda Bethea details how the marketer of brands including Oikos and Silk is approaching artificial intelligence and emerging ...

A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had increased by about $1,338 per member, compared with a matched control ...

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...

A MOTHER has revealed that she has lost 10 and a half stone after using Mounjaro.  Becca Banks, a mum-of-one from the UK, ...

As the old saying goes, “an ounce of prevention is worth a pound of cure,” and in my decades of experience in healthcare that ...

Older people with obesity and overweight require access to proven treatment options and care to improve overall health and reduce other related health care costs. This briefing will feature medical ...

A large majority of older Americans feel that health insurance – including Medicare – should cover anti-obesity medications, according to a new University of Michigan study.

A MOTHER has revealed that she lost over seven stone in just seven months after taking weight loss drug Mounjaro. Layla Angus ...